Pancreatic Cancer Research

ResearcherTongji HospitalActive in the last 2 years

Yiming Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0393-1818; OpenAlex author ID A5113395293. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2025: 2 papers

Papers 2

  1. Post-Translational Modifications: Key "Regulators" of Pancreatic Cancer Malignant Phenotype-Advances in Mechanisms and Targeted Therapies. Last author DOI 10.3390/biomedicines13123013↗
  2. Single-Cell Sequencing Unravels Pancreatic Cancer: Novel Technologies Reveal Novel Aspects of Cellular Heterogeneity and Inform Therapeutic Strategies. Co-author DOI 10.3390/biomedicines13123024↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yongkang Shi · 1 shared paper, 2025 · strength 0.42
  2. Renyi Qin · 1 shared paper, 2025 · strength 0.42
  3. Kexin Chen · 1 shared paper, 2025 · strength 0.25
  4. Bin Xu · 1 shared paper, 2025 · strength 0.25
  5. Tiancheng Xu · 1 shared paper, 2025 · strength 0.25
  6. Guanhu Yang · 1 shared paper, 2025 · strength 0.25

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.